245 related articles for article (PubMed ID: 20518742)
1. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
[TBL] [Abstract][Full Text] [Related]
2. Activation of a membrane-bound serine protease matriptase on the cell surface.
Miyake Y; Yasumoto M; Tsuzuki S; Fushiki T; Inouye K
J Biochem; 2009 Aug; 146(2):273-82. PubMed ID: 19398443
[TBL] [Abstract][Full Text] [Related]
3. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
[TBL] [Abstract][Full Text] [Related]
4. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
[TBL] [Abstract][Full Text] [Related]
5. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).
Ahmed S; Jin X; Yagi M; Yasuda C; Sato Y; Higashi S; Lin CY; Dickson RB; Miyazaki K
FEBS J; 2006 Feb; 273(3):615-27. PubMed ID: 16420484
[TBL] [Abstract][Full Text] [Related]
6. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin.
Jin X; Hirosaki T; Lin CY; Dickson RB; Higashi S; Kitamura H; Miyazaki K
J Cell Biochem; 2005 Jun; 95(3):632-47. PubMed ID: 15832373
[TBL] [Abstract][Full Text] [Related]
7. The optimal activity of a pseudozymogen form of recombinant matriptase under the mildly acidic pH and low ionic strength conditions.
Inouye K; Yasumoto M; Tsuzuki S; Mochida S; Fushiki T
J Biochem; 2010 Apr; 147(4):485-92. PubMed ID: 19919953
[TBL] [Abstract][Full Text] [Related]
8. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
[TBL] [Abstract][Full Text] [Related]
10. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity.
Tseng CC; Jia B; Barndt R; Gu Y; Chen CY; Tseng IC; Su SF; Wang JK; Johnson MD; Lin CY
PLoS One; 2017; 12(8):e0183507. PubMed ID: 28829816
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Kyrieleis OJ; Huber R; Ong E; Oehler R; Hunter M; Madison EL; Jacob U
FEBS J; 2007 Apr; 274(8):2148-60. PubMed ID: 17388811
[TBL] [Abstract][Full Text] [Related]
12. Roles and regulation of membrane-associated serine proteases.
Qiu D; Owen K; Gray K; Bass R; Ellis V
Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
[TBL] [Abstract][Full Text] [Related]
13. Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.
Kojima K; Tsuzuki S; Fushiki T; Inouye K
J Biochem; 2009 Jun; 145(6):783-90. PubMed ID: 19276202
[TBL] [Abstract][Full Text] [Related]
14. The role of asparagine-linked glycosylation site on the catalytic domain of matriptase in its zymogen activation.
Miyake Y; Tsuzuki S; Mochida S; Fushiki T; Inouye K
Biochim Biophys Acta; 2010 Jan; 1804(1):156-65. PubMed ID: 19800422
[TBL] [Abstract][Full Text] [Related]
15. Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro.
Stallmach R; Gloor SM
Biochem J; 2008 May; 412(1):81-91. PubMed ID: 18215125
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding.
Jiang J; Yang J; Feng P; Zuo B; Dong N; Wu Q; He Y
J Biol Chem; 2014 Jul; 289(28):19500-7. PubMed ID: 24867957
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and tissue-specific expression analysis of mouse spinesin, a type II transmembrane serine protease 5.
Watanabe Y; Okui A; Mitsui S; Kawarabuki K; Yamaguchi T; Uemura H; Yamaguchi N
Biochem Biophys Res Commun; 2004 Nov; 324(1):333-40. PubMed ID: 15465023
[TBL] [Abstract][Full Text] [Related]
18. Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.
Inouye K; Tomoishi M; Yasumoto M; Miyake Y; Kojima K; Tsuzuki S; Fushiki T
J Biochem; 2013 Jan; 153(1):51-61. PubMed ID: 23038671
[TBL] [Abstract][Full Text] [Related]
19. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
[TBL] [Abstract][Full Text] [Related]
20. From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion.
Wadhawan V; Kolhe YA; Sangith N; Gautam AK; Venkatraman P
Biochem J; 2012 Oct; 447(1):61-70. PubMed ID: 22783993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
